Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Biological & Pharmaceutical Bulletin|December 2, 2021
Discover Novel Covalent Inhibitors Targeting FLT3 through Hybrid Virtual Screening StrategyShengquan Hu, Jing Liu, Sikang Chen, et al.
Expert Opinion on Therapeutic Patents|October 21, 2023
An updated patent review of AKT inhibitors (2020 - present)Linjie Li, Yu Guo, Yang Lu, et al.
ACS Applied Bio Materials|January 11, 2022
Selectivity Comparison of Tumor-Imaging Probes Designed Based on Various Tumor-Targeting Strategies: A Proof of Concept StudyRui-Ying Guo, Han-Min Wang, Xiaowu Dong, et al.
Chemical Communications (Cambridge, England)|April 18, 2019
Visible-light-mediated guest trapping in a photosensitizing porous coordination network: metal-free C-C bond-forming modification of metal-organic frameworks for aqueous-phase herbicide adsorptionYong Yang, Jinxin Che, Biao Wang, et al.
European Journal of Medicinal Chemistry|February 24, 2011
Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agentsJing Chen, Tao Liu, Rui Wu, et al.
Chemical Biology & Drug Design|January 12, 2012
QSAR models for isoindolinone-based p53-MDM2 interaction inhibitors using linear and non-linear statistical methodsXiaowu Dong, Jingying Yan, Dong Lu, et al.
European Journal of Medicinal Chemistry|March 5, 2013
Structure-based drug design using GPCR homology modeling: toward the discovery of novel selective CysLT2 antagonistsXiaowu Dong, Yanmei Zhao, Xueqin Huang, et al.
Plos One|January 12, 2013
Design, synthesis and biological evaluation of novel piperazine derivatives as CCR5 antagonistsTao Liu, Zhiyong Weng, Xiaowu Dong, et al.
Molecules (Basel, Switzerland)|October 1, 2011
Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studiesXiaowu Dong, Yanming Wang, Tao Liu, et al.
Bioorganic & Medicinal Chemistry|July 13, 2010
Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonistsXiaowu Dong, Li Wang, Xueqin Huang, et al.
Pageof 18